Market SynopsisThe Global Radiopharmaceuticals Market is valued at USD 6.8 Billion in 2024 and is projected to reach a value of USD 19.15 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of ...

An overview of cyclotron development in research laboratories worldwide and the impressive growth of commercial cyclotrons during the last 50 years are summarized. The role of the superconducting ...

Aiming at the statistical limitations of isotope identification Methods by gamma spectroscopy, this paper studies a method of isotope recognition based on improved Hilbert-Huang Transform (HHT) ...

Astatine is the rarest naturally occurring element on Earth and one of the least studied within the periodic table, mostly because it lives up to its name, which is the Greek word for "unstable." ...

The Texas A&M University Cyclotron Institute-led medical isotope program has perfected routine production and distribution of astatine-211, a short-lived alpha-emitting radioisotope that shows ...

Key Points: To better understand the dynamics of the medical cyclotron market, it is essential to consider these key highlights: The demand for technetium-99m and fluorine-18, key radioisotopes, is ...

On June 17, Oklo announced that its subsidiary called Atomic Alchemy Inc., has commenced site characterization work for a commercial radioisotope production facility at the Idaho National ...

Atomic Alchemy, a subsidiary of US-based Oklo, has begun site characterisation work at a potential location for a commercial radioisotope production facility at the US Department of Energy’s (DOE’s) ...